Philip Koch

Dr. Philip Koch

Hector Institute for Translational Brain Research (HITBR), Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim J5, 68159 Mannheim, Germany.
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PKPhilip Koch
Philip Koch
TOThoralf Opitz
Thoralf Opitz
JSJulius A. Steinbeck
Julius A. Steinbeck
JLJulia Ladewig
Julia Ladewig
OBOliver Brüstle
Oliver Brüstle
An intriguing question in human embryonic stem cell (hESC) biology is whether these pluripotent cells can give rise to stably expandable somatic stem cells, which are still amenable to extrinsic fate instruction. Here, we present a pure population of long-term self-renewing rosette-type hESC-derived neural stem cells (lt-hESNSCs), which exhibit extensive self-renewal, clonogenicity, and stable neurogenesis. Although lt-hESNSCs show a restricted expression of regional transcription factors, they retain responsiveness to instructive cues promoting the induction of distinct subpopulations, such as ventral midbrain and spinal cord fates. Using lt-hESNSCs as a donor source for neural transplantation, we provide direct evidence that hESC-derived neurons can establish synaptic connectivity with the mammalian nervous system. Combining long-term stability, maintenance of rosette-properties and phenotypic plasticity, lt-hESNSCs may serve as useful tool to study mechanisms of human NSC self-renewal, lineage segregation, and functional in vivo integration.

17 January 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AFAnna Falk
Anna Falk
PKPhilip Koch
Philip Koch
JKJaideep Kesavan
Jaideep Kesavan
YTYasuhiro Takashima
Yasuhiro Takashima
JLJulia Ladewig
Julia Ladewig
OBOliver Brüstle
Oliver Brüstle
Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects for studying human neurodevelopment and modeling neurological disease. In particular, iPSC-derived neural cells permit a direct comparison of disease-relevant molecular pathways in neurons and glia derived from patients and healthy individuals. A prerequisite for such comparative studies are robust protocols that efficiently yield standardized populations of neural cell types. Here we show that long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from 3 hESC and 6 iPSC lines in two independent laboratories exhibit consistent characteristics including i) continuous expandability in the presence of FGF2 and EGF; ii) stable neuronal and glial differentiation competence; iii) characteristic transcription factor profile; iv) hindbrain specification amenable to regional patterning; v) capacity to generate functionally mature human neurons. We further show that lt-NES cells are developmentally distinct from fetal tissue-derived radial glia-like stem cells. We propose that lt-NES cells provide an interesting tool for studying human neurodevelopment and may serve as a standard system to facilitate comparative analyses of hESC and hiPSC-derived neural cells from control and diseased genetic backgrounds.

8 April 2012 in Nature Methods
Verified
Journal Article
Closed access
JLJulia Ladewig
Julia Ladewig
JMJerome Mertens
Jerome Mertens
JKJaideep Kesavan
Jaideep Kesavan
JDJonas Doerr
Jonas Doerr
DPDaniel Poppe
Daniel Poppe
OBOliver Brüstle
Oliver Brüstle

23 November 2011 in Nature
Verified
Journal Article
Closed access
PKPhilip Koch
Philip Koch
PBPeter Breuer
Peter Breuer
MPMichael Peitz
Michael Peitz
JJJohannes Jungverdorben
Johannes Jungverdorben
JKJaideep Kesavan
Jaideep Kesavan
OBOliver Brüstle
Oliver Brüstle

14 December 2022 in Nature
Verified
Journal Article
Closed access
PDF file
DHDavid Hausmann
David Hausmann
DHDirk C. Hoffmann
Dirk C. Hoffmann
VVVarun Venkataramani
Varun Venkataramani
EJErik Jung
Erik Jung
SHSandra Horschitz
Sandra Horschitz
FWFrank Winkler
Frank Winkler

11 April 2012 in Stem Cells
Verified
Journal Article
Open access
PDF file
KOKoichi Oki
Koichi Oki
JTJemal Tatarishvili
Jemal Tatarishvili
JWJames Wood
James Wood
PKPhilip Koch
Philip Koch
SWSomsak Wattananit
Somsak Wattananit
Zaal KokaiaZaal Kokaia
Zaal Kokaia
Reprogramming of adult human somatic cells to induced pluripotent stem cells (iPSCs) is a novel approach to produce patient-specific cells for autologous transplantation. Whether such cells survive long-term, differentiate to functional neurons, and induce recovery in the stroke-injured brain are unclear. We have transplanted long-term self-renewing neuroepithelial-like stem cells, generated from adult human fibroblast-derived iPSCs, into the stroke-damaged mouse and rat striatum or cortex. Recovery of forepaw movements was observed already at 1 week after transplantation. Improvement was most likely not due to neuronal replacement but was associated with increased vascular endothelial growth factor levels, probably enhancing endogenous plasticity. Transplanted cells stopped proliferating, could survive without forming tumors for at least 4 months, and differentiated to morphologically mature neurons of different subtypes. Neurons in intrastriatal grafts sent axonal projections to the globus pallidus. Grafted cells exhibited electrophysiological properties of mature neurons and received synaptic input from host neurons. Our study provides the first evidence that transplantation of human iPSC-derived cells is a safe and efficient approach to promote recovery after stroke and can be used to supply the injured brain with new neurons for replacement. STEM CELLS2012;30:1120–1133